What changed
2026-07-31 20:59 UTC → 2026-08-17 10:39 UTC ·
added
removed
Global escalation of antimicrobial resistance surge and emerging対策
Researchers continue to document the expanding The threat of antimicrobial resistance, especially among children. A follow‑up analysis of more than 106,000 bacterial isolates from patients under 18 in 82 countries between 2004 and 2022 confirmed that resistance has risen (AMR) continues to expand across all regions, with the sharpest increases seen in infants, intensive‑care patients clinical and low‑resource settings. Acinetobacter baumannii is now resistant environmental sectors. Recent data indicates that in over 55 % of cases and Klebsiella species are rapidly acquiring resistance 2019, approximately 1.27 million deaths were directly attributable to cephalosporins and carbapenems; models project carbapenem resistance bacterial resistance, with nearly 5 million associated deaths; projections suggest direct annual deaths could reach 82 % in A. baumannii and 35 % in Klebsiella 1.91 million by 2035, and third‑ 2050. In clinical settings, hospitals report the rapid spread of drug-resistant infections in intensive-care units, specifically involving carbapenem-resistant Enterobacteriaceae and fourth‑generation cephalosporin multidrug-resistant Acinetobacter baumannii. This follows previous findings that resistance may exceed 70 % is rising globally, particularly among infants and children in some areas. low-resource settings. The report highlighted a 13‑year‑old Australian kidney‑transplant recipient who now requires costly intravenous therapy because standard antibiotics fail. Authors call for age‑stratified surveillance, stronger stewardship programmes crisis extends to the food supply. A systematic review of 749 prevalence surveys from Asian aquaculture between 2000 and improved sanitation 2019 found that 33% of farmed aquatic animals carry multi-drug-resistant bacteria, with hotspots in low‑income countries, building on earlier calls for pediatric‑focused drug development China, India, and global tracking platforms. Indonesia, raising concerns about transmission from food animals to humans. In response, researchers are developing new therapeutic strategies. At Cold Spring Harbor Laboratory, scientists are using a diversity-oriented-clicking (DOC) method to create a library of over 150 antibiotic adjuvants designed to restore the effectiveness of existing drugs. Other emerging medical innovations include engineered bacteriophages, CRISPR systems, antimicrobial peptides, and the use of artificial intelligence to design new molecules to neutralize resistant pathogens while protecting the beneficial microbiome.